Literature DB >> 3741380

The metabolic route by which oleate is converted into cholesterol in rat hepatocytes.

G F Gibbons, C P Attwell Thomas, C R Pullinger.   

Abstract

The effect of (-)-hydroxycitrate on the conversion of [1-14C]oleate into cholesterol was dependent on the time of day at which the cells were prepared and on the extracellular oleate concentration. In hepatocytes prepared during the light phase of the diurnal cycle (L2-hepatocytes), (-)-hydroxycitrate inhibited the conversion of L-[U-14C]lactate (2 mM) and of 0.13 mM-[1-14C]oleate into cholesterol. However, when [1-14C]oleate was present at 1.3 mM, most of the sterol carbon was derived from this source, and under these conditions (-)-hydroxycitrate had no inhibitory effect on [14C]cholesterol formation. In these cells, non-radioactive acetoacetate blocked the conversion of 1.3 mM-[1-14C]oleate, but not of 0.13 mM-[1-14C]oleate, into cholesterol. In cells prepared during the dark phase of the diurnal cycle (D6-hepatocytes), irrespective of the concentration of [1-14C]oleate, (-)-hydroxycitrate decreased its conversion into cholesterol. In both types of cell preparation, the inhibitory effect of (-)-hydroxycitrate on the conversion of L-[U-14C]lactate into cholesterol was greater than that on the overall rate of cholesterol production from all endogenous sources. These results provide evidence for the following. (1) The major metabolic route by which oleate is converted into cholesterol is dependent on its extracellular concentration. (2) When oleate is the major source of hepatic sterol carbon, the flux of substrate through citrate into cholesterol is dependent on the nutritional state of the animal. (3) When endogenous substrates are the sole source of sterol carbon, a substantial proportion of the carbon enters the cholesterol pathway through routes not involving citrate cleavage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741380      PMCID: PMC1146642          DOI: 10.1042/bj2350019

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Inhibition of cholesterol synthesis by (-)-hydroxycitrate in perfused rat liver. Evidence for an extramitochondrial mevalonate synthesis from acetyl coenzyme A.

Authors:  C Barth; J Hackenschmidt; H Ullmann; K Decker
Journal:  FEBS Lett       Date:  1972-05-15       Impact factor: 4.124

2.  3- -Hydroxysterol synthesis by the liver.

Authors:  H Brunengraber; J R Sabine; M Boutry; J M Lowenstein
Journal:  Arch Biochem Biophys       Date:  1972-06       Impact factor: 4.013

3.  Tricarboxylic acid cycle intermediates and the control of fatty acid synthesis and ketogenesis.

Authors:  M D Lane; R A Mooney
Journal:  Curr Top Cell Regul       Date:  1981

Review 4.  Regulation of HMG-CoA reductase.

Authors:  V W Rodwell; J L Nordstrom; J J Mitschelen
Journal:  Adv Lipid Res       Date:  1976

5.  Acetoacetyl-coenzyme A synthetase activity in rat liver cytosol: a regulated enzyme in lipogenesis.

Authors:  J D Bergstrom; K A Robbins; J Edmond
Journal:  Biochem Biophys Res Commun       Date:  1982-06-15       Impact factor: 3.575

6.  Utilization of endogenous and exogenous sources of substrate for cholesterol biosynthesis by isolated hepatocytes.

Authors:  G F Gibbons; C R Pullinger
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

7.  Fatty acid synthesis in liver and adipose tissue of normal and genetically obese (ob/ob) mice during the 24-hour cycle.

Authors:  D A Hems; E A Rath; T R Verrinder
Journal:  Biochem J       Date:  1975-08       Impact factor: 3.857

8.  The relationship between the rate of hepatic sterol synthesis and the incorporation of [3H]water.

Authors:  C R Pullinger; G F Gibbons
Journal:  J Lipid Res       Date:  1983-10       Impact factor: 5.922

9.  The regulation of acetoacetyl-CoA synthetase activity by modulators of cholesterol synthesis in vivo and the utilization of acetoacetate for cholesterogenesis.

Authors:  J D Bergstrom; G A Wong; P A Edwards; J Edmond
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

10.  Diurnal variations in food intake and in lipogenesis in mammary gland and liver of lactating rats.

Authors:  M R Munday; D H Williamson
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

View more
  9 in total

1.  Regulation of hepatic synthesis and secretion of cholesterol and glycerolipids in animals maintained in different nutritional states.

Authors:  J M Duerden; B Marsh; F J Burnham; G F Gibbons
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

2.  A relationship between the activities of hepatic lanosterol 14 alpha-demethylase and 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  C Marco de la Calle; W Hwang; C R Pullinger; G F Gibbons
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

3.  The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.

Authors:  T A Berkhout; L M Havekes; N J Pearce; P H Groot
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

4.  Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.

Authors:  J Iglesias; G F Gibbons
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

5.  Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat.

Authors:  G F Gibbons; C R Pullinger
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

6.  Diurnal variations in the effects of an unsaturated-fat-containing diet on fatty acid and cholesterol synthesis in rat hepatocytes.

Authors:  G F Gibbons; C R Pullinger
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

7.  Hepatic and intestinal formation of polar sterols in vivo in animals fed on a cholesterol-supplemented diet.

Authors:  C Marco de la Calle; G F Gibbons
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

8.  Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes.

Authors:  J M Duerden; G F Gibbons
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

9.  Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling.

Authors:  Hong Tang; Ruili Yu; Shiying Liu; Bahetiyaer Huwatibieke; Ziru Li; Weizhen Zhang
Journal:  EBioMedicine       Date:  2016-02-27       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.